Copyright Reports & Markets. All rights reserved.

Global Antibody Production Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Antibody Production Services
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Antibody Production Services by Type
    • 1.3.1 Overview: Global Antibody Production Services Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Antibody Production Services Consumption Value Market Share by Type in 2023
    • 1.3.3 IgM
    • 1.3.4 IgG
    • 1.3.5 IgA
    • 1.3.6 Other
  • 1.4 Global Antibody Production Services Market by Application
    • 1.4.1 Overview: Global Antibody Production Services Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Therapeutic
    • 1.4.3 Research
    • 1.4.4 Diagnostic
  • 1.5 Global Antibody Production Services Market Size & Forecast
  • 1.6 Global Antibody Production Services Market Size and Forecast by Region
    • 1.6.1 Global Antibody Production Services Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Antibody Production Services Market Size by Region, (2019-2030)
    • 1.6.3 North America Antibody Production Services Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Antibody Production Services Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Antibody Production Services Market Size and Prospect (2019-2030)
    • 1.6.6 South America Antibody Production Services Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Antibody Production Services Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Antibody Production Services Product and Solutions
    • 2.1.4 Roche Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Antibody Production Services Product and Solutions
    • 2.2.4 Johnson & Johnson Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Antibody Production Services Product and Solutions
    • 2.3.4 Merck Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Merck Recent Developments and Future Plans
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Antibody Production Services Product and Solutions
    • 2.4.4 Novartis Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novartis Recent Developments and Future Plans
  • 2.5 AbbVie
    • 2.5.1 AbbVie Details
    • 2.5.2 AbbVie Major Business
    • 2.5.3 AbbVie Antibody Production Services Product and Solutions
    • 2.5.4 AbbVie Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 AbbVie Recent Developments and Future Plans
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Antibody Production Services Product and Solutions
    • 2.6.4 Amgen Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Amgen Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Antibody Production Services Product and Solutions
    • 2.7.4 Pfizer Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 Bayer
    • 2.8.1 Bayer Details
    • 2.8.2 Bayer Major Business
    • 2.8.3 Bayer Antibody Production Services Product and Solutions
    • 2.8.4 Bayer Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Bayer Recent Developments and Future Plans
  • 2.9 Lilly
    • 2.9.1 Lilly Details
    • 2.9.2 Lilly Major Business
    • 2.9.3 Lilly Antibody Production Services Product and Solutions
    • 2.9.4 Lilly Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Lilly Recent Developments and Future Plans
  • 2.10 Bristol-Myers Squibb
    • 2.10.1 Bristol-Myers Squibb Details
    • 2.10.2 Bristol-Myers Squibb Major Business
    • 2.10.3 Bristol-Myers Squibb Antibody Production Services Product and Solutions
    • 2.10.4 Bristol-Myers Squibb Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.11 GlaxoSmithKline
    • 2.11.1 GlaxoSmithKline Details
    • 2.11.2 GlaxoSmithKline Major Business
    • 2.11.3 GlaxoSmithKline Antibody Production Services Product and Solutions
    • 2.11.4 GlaxoSmithKline Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.12 Biogen
    • 2.12.1 Biogen Details
    • 2.12.2 Biogen Major Business
    • 2.12.3 Biogen Antibody Production Services Product and Solutions
    • 2.12.4 Biogen Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Biogen Recent Developments and Future Plans
  • 2.13 AstraZeneca
    • 2.13.1 AstraZeneca Details
    • 2.13.2 AstraZeneca Major Business
    • 2.13.3 AstraZeneca Antibody Production Services Product and Solutions
    • 2.13.4 AstraZeneca Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 AstraZeneca Recent Developments and Future Plans
  • 2.14 Sanofi
    • 2.14.1 Sanofi Details
    • 2.14.2 Sanofi Major Business
    • 2.14.3 Sanofi Antibody Production Services Product and Solutions
    • 2.14.4 Sanofi Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Sanofi Recent Developments and Future Plans
  • 2.15 Alexion Pharmaceuticals
    • 2.15.1 Alexion Pharmaceuticals Details
    • 2.15.2 Alexion Pharmaceuticals Major Business
    • 2.15.3 Alexion Pharmaceuticals Antibody Production Services Product and Solutions
    • 2.15.4 Alexion Pharmaceuticals Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Alexion Pharmaceuticals Recent Developments and Future Plans
  • 2.16 Seattle Genetics
    • 2.16.1 Seattle Genetics Details
    • 2.16.2 Seattle Genetics Major Business
    • 2.16.3 Seattle Genetics Antibody Production Services Product and Solutions
    • 2.16.4 Seattle Genetics Antibody Production Services Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Seattle Genetics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Antibody Production Services Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Antibody Production Services by Company Revenue
    • 3.2.2 Top 3 Antibody Production Services Players Market Share in 2023
    • 3.2.3 Top 6 Antibody Production Services Players Market Share in 2023
  • 3.3 Antibody Production Services Market: Overall Company Footprint Analysis
    • 3.3.1 Antibody Production Services Market: Region Footprint
    • 3.3.2 Antibody Production Services Market: Company Product Type Footprint
    • 3.3.3 Antibody Production Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Antibody Production Services Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Antibody Production Services Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Antibody Production Services Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Antibody Production Services Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Antibody Production Services Consumption Value by Type (2019-2030)
  • 6.2 North America Antibody Production Services Consumption Value by Application (2019-2030)
  • 6.3 North America Antibody Production Services Market Size by Country
    • 6.3.1 North America Antibody Production Services Consumption Value by Country (2019-2030)
    • 6.3.2 United States Antibody Production Services Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Antibody Production Services Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Antibody Production Services Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Antibody Production Services Consumption Value by Type (2019-2030)
  • 7.2 Europe Antibody Production Services Consumption Value by Application (2019-2030)
  • 7.3 Europe Antibody Production Services Market Size by Country
    • 7.3.1 Europe Antibody Production Services Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Antibody Production Services Market Size and Forecast (2019-2030)
    • 7.3.3 France Antibody Production Services Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Antibody Production Services Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Antibody Production Services Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Antibody Production Services Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Antibody Production Services Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Antibody Production Services Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Antibody Production Services Market Size by Region
    • 8.3.1 Asia-Pacific Antibody Production Services Consumption Value by Region (2019-2030)
    • 8.3.2 China Antibody Production Services Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Antibody Production Services Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Antibody Production Services Market Size and Forecast (2019-2030)
    • 8.3.5 India Antibody Production Services Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Antibody Production Services Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Antibody Production Services Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Antibody Production Services Consumption Value by Type (2019-2030)
  • 9.2 South America Antibody Production Services Consumption Value by Application (2019-2030)
  • 9.3 South America Antibody Production Services Market Size by Country
    • 9.3.1 South America Antibody Production Services Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Antibody Production Services Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Antibody Production Services Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Antibody Production Services Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Antibody Production Services Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Antibody Production Services Market Size by Country
    • 10.3.1 Middle East & Africa Antibody Production Services Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Antibody Production Services Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Antibody Production Services Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Antibody Production Services Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Antibody Production Services Market Drivers
  • 11.2 Antibody Production Services Market Restraints
  • 11.3 Antibody Production Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Antibody Production Services Industry Chain
  • 12.2 Antibody Production Services Upstream Analysis
  • 12.3 Antibody Production Services Midstream Analysis
  • 12.4 Antibody Production Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antibody Production Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
    In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
    The Global Info Research report includes an overview of the development of the Antibody Production Services industry chain, the market status of Therapeutic (IgM, IgG), Research (IgM, IgG), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Production Services.
    Regionally, the report analyzes the Antibody Production Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Production Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Antibody Production Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Production Services industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IgM, IgG).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Production Services market.
    Regional Analysis: The report involves examining the Antibody Production Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Production Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Antibody Production Services:
    Company Analysis: Report covers individual Antibody Production Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Production Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Therapeutic, Research).
    Technology Analysis: Report covers specific technologies relevant to Antibody Production Services. It assesses the current state, advancements, and potential future developments in Antibody Production Services areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Production Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Antibody Production Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    IgM
    IgG
    IgA
    Other
    Market segment by Application
    Therapeutic
    Research
    Diagnostic
    Market segment by players, this report covers
    Roche
    Johnson & Johnson
    Merck
    Novartis
    AbbVie
    Amgen
    Pfizer
    Bayer
    Lilly
    Bristol-Myers Squibb
    GlaxoSmithKline
    Biogen
    AstraZeneca
    Sanofi
    Alexion Pharmaceuticals
    Seattle Genetics
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Antibody Production Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Antibody Production Services, with revenue, gross margin and global market share of Antibody Production Services from 2019 to 2024.
    Chapter 3, the Antibody Production Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Production Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Production Services.
    Chapter 13, to describe Antibody Production Services research findings and conclusion.

    Buy now